| Page 45 | Cafepharma

You are here

Primary tabs

Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination

Post date: September 6, 2018 - 9:20am

[sponsored] Orange Book Companion® Adds New Features and Capabilities

Post date: September 5, 2018 - 1:34pm

Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma

Post date: September 5, 2018 - 9:24am

FDA Approves Clinical Trial of Tuberculosis Vaccine for Fibromyalgia

Post date: September 5, 2018 - 9:08am

Microbiome Focused Seres Therapeutics Adds Experienced Biopharmaceutical Financial Leader to Board of Directors

Post date: September 4, 2018 - 10:02am

LEO Pharma Closes Acquisition of Bayer’s Prescription Dermatology Business in the US

Post date: September 4, 2018 - 9:55am

Boehringer Ingelheim and Tsinghua University Collaborate to Harness the Immune System to Better Fight Infectious Diseases

Post date: September 4, 2018 - 9:44am

On the Heels of $20 Million Funding Round, Macrolide Adds Scientific and Financial Expertise

Post date: September 4, 2018 - 9:28am

Sunovion Receives Bad News From the FDA About ADHD Drug

Post date: August 31, 2018 - 10:42am

China Approves Gilead's Genvoya for HIV-1 Infection

Post date: August 6, 2018 - 9:35am

Pages